Chloropicrin From China; Termination of Five-Year Review, 71944 [2020-24983]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES 71944 Federal Register / Vol. 85, No. 219 / Thursday, November 12, 2020 / Notices Lines, Inv. No. 337–TA–360, USITC Pub. No. 2843, Comm’n Op. at 7–10 (Dec. 1994). The statute requires the Commission to consider the effects of that remedy upon the public interest. The public interest factors the Commission will consider include the effect that an exclusion order would have on: (1) The public health and welfare, (2) competitive conditions in the U.S. economy, (3) U.S. production of articles that are like or directly competitive with those that are subject to investigation, and (4) U.S. consumers. The Commission is therefore interested in receiving written submissions that address the aforementioned public interest factors in the context of this investigation. If the Commission orders some form of remedy, the U.S. Trade Representative, as delegated by the President, has 60 days to approve, disapprove, or take no action on the Commission’s determination. See Presidential Memorandum of July 21, 2005, 70 FR 43251 (July 26, 2005). During this period, the subject articles would be entitled to enter the United States under bond, in an amount determined by the Commission and prescribed by the Secretary of the Treasury. The Commission is therefore interested in receiving submissions concerning the amount of the bond that should be imposed if a remedy is ordered. Written Submissions: Parties to the investigation, interested government agencies, and any other interested parties are encouraged to file written submissions on the issues of remedy, the public interest, and bonding. Such submissions should address the recommended determination by the ALJ on remedy and bonding. In their initial submissions, Complainant is also requested to identify the remedy sought and Complainant and OUII are requested to submit proposed remedial orders for the Commission’s consideration. Complainant is further requested to state the date that the Asserted Patent expires, to provide the HTSUS subheadings under which the accused products are imported and to supply the identification information for all known importers of the products at issue in this investigation. The initial written submissions and proposed remedial orders must be filed no later than close of business on Monday, November 23, 2020. Reply submissions must be filed no later than the close of business on Monday, November 30, 2020. No further submissions on these issues will be VerDate Sep<11>2014 17:07 Nov 10, 2020 Jkt 253001 permitted unless otherwise ordered by the Commission. Persons filing written submissions must file the original document electronically on or before the deadlines stated above. The Commission’s paper filing requirements in 19 CFR 210.4(f) are currently waived. 85 FR 15798 (March 19, 2020). Submissions should refer to the investigation number (Inv. No. 337–TA–1183) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, https://www.usitc.gov/ documents/handbook_on_filing_ procedures.pdf). Persons with questions regarding filing should contact the Secretary, (202) 205–2000. Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. A redacted nonconfidential version of the document must also be filed simultaneously with any confidential filing. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel, solely for cybersecurity purposes. All contract personnel will sign appropriate nondisclosure agreements. All nonconfidential written submissions will be available for public inspection on EDIS. The Commission vote for this determination took place on November 5, 2020. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. PO 00000 Frm 00070 Fmt 4703 Sfmt 9990 Issued: November 5, 2020. Lisa Barton, Secretary to the Commission. [FR Doc. 2020–24984 Filed 11–10–20; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 731–TA–130 (Fifth Review)] Chloropicrin From China; Termination of Five-Year Review United States International Trade Commission. ACTION: Notice. AGENCY: The Commission instituted the subject five-year review on August 3, 2020 (85 FR 46722) to determine whether revocation of the antidumping duty order on chloropicrin from China would be likely to lead to continuation or recurrence of material injury. The Department of Commerce issued notice that it was revoking the order effective September 22, 2020, because the domestic interested parties did not file a timely response in this review (see Chloropicrin from the People’s Republic of China: Final Results of Sunset Review and Revocation of Order, issued November 2, 2020). DATES: Applicable September 22, 2020 (effective date of revocation of order). FOR FURTHER INFORMATION CONTACT: Jason Duncan (202–205–3432), Office of Investigations, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Hearingimpaired individuals are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server (https:// www.usitc.gov). SUMMARY: Authority: This review is being terminated under authority of title VII of the Tariff Act of 1930 and pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)). This notice is published pursuant to § 207.69 of the Commission’s rules (19 CFR 207.69). By order of the Commission. Issued: November 5, 2020. Lisa Barton, Secretary to the Commission. [FR Doc. 2020–24983 Filed 11–10–20; 8:45 am] BILLING CODE 7020–02–P E:\FR\FM\12NON1.SGM 12NON1

Agencies

[Federal Register Volume 85, Number 219 (Thursday, November 12, 2020)]
[Notices]
[Page 71944]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24983]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-130 (Fifth Review)]


Chloropicrin From China; Termination of Five-Year Review

AGENCY:  United States International Trade Commission.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Commission instituted the subject five-year review on 
August 3, 2020 (85 FR 46722) to determine whether revocation of the 
antidumping duty order on chloropicrin from China would be likely to 
lead to continuation or recurrence of material injury. The Department 
of Commerce issued notice that it was revoking the order effective 
September 22, 2020, because the domestic interested parties did not 
file a timely response in this review (see Chloropicrin from the 
People's Republic of China: Final Results of Sunset Review and 
Revocation of Order, issued November 2, 2020).

DATES:  Applicable September 22, 2020 (effective date of revocation of 
order).

FOR FURTHER INFORMATION CONTACT:  Jason Duncan (202-205-3432), Office 
of Investigations, U.S. International Trade Commission, 500 E Street 
SW, Washington, DC 20436. Hearing-impaired individuals are advised that 
information on this matter can be obtained by contacting the 
Commission's TDD terminal on 202-205-1810. Persons with mobility 
impairments who will need special assistance in gaining access to the 
Commission should contact the Office of the Secretary at 202-205-2000. 
General information concerning the Commission may also be obtained by 
accessing its internet server (https://www.usitc.gov).

    Authority:  This review is being terminated under authority of 
title VII of the Tariff Act of 1930 and pursuant to section 751(c) 
of the Tariff Act of 1930 (19 U.S.C. 1675(c)). This notice is 
published pursuant to Sec.  207.69 of the Commission's rules (19 CFR 
207.69).

    By order of the Commission.

    Issued: November 5, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020-24983 Filed 11-10-20; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.